Pharmacokinetic and Pharmacodynamic Interactions Between Metformin and a Novel Dipeptidyl Peptidase-4 Inhibitor, Evogliptin, in Healthy Subjects

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s110712

Related search